dc.contributor.author | Agirbasli, Mehmet | |
dc.contributor.author | Can, Guenay | |
dc.contributor.author | Hergenc, Guelay | |
dc.contributor.author | KAYA, Zekeriya | |
dc.contributor.author | Uenaltuna, Nihan | |
dc.contributor.author | ONAT, Altan | |
dc.date.accessioned | 2021-03-02T20:21:46Z | |
dc.date.available | 2021-03-02T20:21:46Z | |
dc.date.issued | 2009 | |
dc.identifier.citation | ONAT A., Hergenc G., Agirbasli M., KAYA Z., Can G., Uenaltuna N., "Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking", CLINICAL CHEMISTRY AND LABORATORY MEDICINE, cilt.47, sa.2, ss.208-215, 2009 | |
dc.identifier.issn | 1434-6621 | |
dc.identifier.other | av_019bedb6-5dcb-4959-a89b-0ef23c060a32 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/7050 | |
dc.identifier.uri | https://doi.org/10.1515/cclm.2009.018 | |
dc.description.abstract | Background: Correlates of preheparin serum lipoprotein lipase (LPL) mass and its associations with the likelihood of metabolic syndrome (MS) and coronary heart disease (CHD) were investigated. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | TIBBİ LABORATUVAR TEKNOLOJİSİ | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.title | Preheparin serum lipoprotein lipase mass interacts with gender, gene polymorphism and, positively, with smoking | |
dc.type | Makale | |
dc.relation.journal | CLINICAL CHEMISTRY AND LABORATORY MEDICINE | |
dc.contributor.department | Turkish Heart Foundation , , | |
dc.identifier.volume | 47 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 208 | |
dc.identifier.endpage | 215 | |
dc.contributor.firstauthorID | 90643 | |